loperamide has been researched along with Disbacteriosis in 6 studies
Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Constipation was induced by 5 mg/kg loperamide days 12 through 14 in all groups except the control." | 7.96 | Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice. ( Hayeeawaema, F; Khuituan, P; Wichienchot, S, 2020) |
| "Constipation has a significant influence on quality of life." | 5.48 | Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats. ( Cong, LM; Deng, Y; He, CY; Li, M; Liu, Y; Mei, L; Yuan, JL; Zhang, BB; Zheng, PY, 2018) |
| " Constipation was induced by 5 mg/kg loperamide days 12 through 14 in all groups except the control." | 3.96 | Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice. ( Hayeeawaema, F; Khuituan, P; Wichienchot, S, 2020) |
| "Loperamide is an opioid-receptor agonist widely prescribed for treating acute diarrhea in humans." | 1.91 | Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition. ( Audrain, B; Bedu, S; Dray, N; Ghigo, JM; Pérez-Pascual, D; Stevick, RJ, 2023) |
| "Constipation has become an epidemic enteric medical problem, accompanied with increasing long-term sequelae." | 1.72 | Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis. ( Bai, J; Cai, Y; Gu, Y; Huang, N; Huang, Z; Liu, R; Sun, R; Zhang, G, 2022) |
| "Constipation has a significant influence on quality of life." | 1.48 | Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats. ( Cong, LM; Deng, Y; He, CY; Li, M; Liu, Y; Mei, L; Yuan, JL; Zhang, BB; Zheng, PY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Liu, B | 1 |
| Cao, J | 1 |
| Zhang, H | 1 |
| Tian, F | 1 |
| Yu, L | 1 |
| Chen, W | 1 |
| Zhai, Q | 1 |
| Bai, J | 1 |
| Cai, Y | 1 |
| Huang, Z | 1 |
| Gu, Y | 1 |
| Huang, N | 1 |
| Sun, R | 1 |
| Zhang, G | 1 |
| Liu, R | 1 |
| Stevick, RJ | 1 |
| Audrain, B | 1 |
| Bedu, S | 1 |
| Dray, N | 1 |
| Ghigo, JM | 1 |
| Pérez-Pascual, D | 1 |
| Hayeeawaema, F | 1 |
| Wichienchot, S | 1 |
| Khuituan, P | 1 |
| Makizaki, Y | 1 |
| Uemoto, T | 1 |
| Yokota, H | 1 |
| Yamamoto, M | 1 |
| Tanaka, Y | 1 |
| Ohno, H | 1 |
| Deng, Y | 1 |
| Li, M | 1 |
| Mei, L | 1 |
| Cong, LM | 1 |
| Liu, Y | 1 |
| Zhang, BB | 1 |
| He, CY | 1 |
| Zheng, PY | 1 |
| Yuan, JL | 1 |
6 other studies available for loperamide and Disbacteriosis
| Article | Year |
|---|---|
Different effects of
Topics: Animals; Bacillus coagulans; Constipation; Dysbiosis; Gastrointestinal Microbiome; Intestinal Diseas | 2022 |
Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis.
Topics: Animals; Constipation; Dysbiosis; Gastrointestinal Microbiome; Gastrointestinal Motility; Loperamide | 2022 |
Anti-diarrheal drug loperamide induces dysbiosis in zebrafish microbiota via bacterial inhibition.
Topics: Animals; Bacteria; Constipation; Dysbiosis; Humans; Loperamide; Microbiota; Zebrafish | 2023 |
Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice.
Topics: Amorphophallus; Animals; Constipation; Dysbiosis; Feces; Gastrointestinal Motility; Gastrointestinal | 2020 |
Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Topics: Animals; Bifidobacterium bifidum; Butyrates; Butyric Acid; Constipation; Disease Models, Animal; Dop | 2021 |
Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats.
Topics: Animals; Antidiarrheals; Constipation; Dysbiosis; Feces; Gastrointestinal Microbiome; Gastrointestin | 2018 |